Sponsor:
The Hospital for Sick Children
Code:
NCT02740868
Conditions
Cystic Fibrosis
Asthma
Eligibility Criteria
Sex: All
Age: 8+
Healthy Volunteers: Accepted
Interventions
Xenon-129 and Perfluoropropane (19F)
Magnetic Resonance Imaging
Lung Clearance Index
Brief summary:
Conditions
Cystic Fibrosis
Asthma
Study ID
NCT02740868
Start date
Aug, 2015
Status verified date
Feb, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 8+
Healthy Volunteers: Accepted
Enrollment
30 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Diagnostic
Arms
active comparator: Healthy
active comparator: Cystic Fibrisos
active comparator: Asthma
Interventions
Xenon-129 and Perfluoropropane (19F)
Magnetic Resonance Imaging
Lung Clearance Index
Primary outcome measure
Central contacts
Locations
The Hospital for Sick Children
Recruiting
Toronto, Ontario, Canada, M5G 1X8
Principal Investigator:
Giles Santyr, PhD FCCPM
Sponsor
The Hospital for Sick Children
Last update posted
Mar 2, 2026
Last verified
Feb, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Hospital for Sick Children on 2026-03-02.